Stock-Based Compensation (Tables)

9 Months Ended

Jun. 30, 2011

Stock Based Compensation Included in Consolidated Statements of Operations

Our share-based awards are accounted for as equity instruments. The amounts included in the consolidated statements of operations relating to stock-based compensation are as follows (dollars in thousands):

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2011		2010		2011		2010
Cost of product and licensing	$	2	$	7	$	29	$	25
Cost of professional services and hosting		5,764		2,612		20,514		8,173
Cost of maintenance and support		518		165		1,545		582
Research and development		5,280		2,282		18,188		6,731
Sales and marketing		10,341		12,516		32,748		29,813
General and administrative		11,883		10,512		36,481		27,544
Total	$	33,788	$	28,094	$	109,505	$	72,868

Summary of Stock Option Activity

The table below summarizes activity relating to stock options for the nine months ended June 30, 2011:

				Weighted		Weighted Average
	Number of			Average		Remaining		Aggregate
	Shares			Exercise Price		Contractual Term		Intrinsic Value(1)
Outstanding at September 30, 2010		10,703,237		$	8.44
Granted		1,000,000		$	16.44
Exercised		(2,448,623	)	$	6.33
Forfeited		(89,553	)	$	12.81
Expired		(63,401	)	$	14.99
Outstanding at June 30, 2011		9,101,660		$	9.79		3.4 years	$	106.3 million
Exercisable at June 30, 2011		6,917,436		$	8.21		2.6 years	$	91.7 million
Exercisable at June 30, 2010		8,021,090		$	6.94		2.9 years	$	65.9 million

(1) The aggregate intrinsic value in this table was calculated based on the positive difference, if any, between the closing market value of our common stock on June 30, 2011 ($21.47) and the exercise price of the underlying options.

Summary of Weighted-Average Grant-Date Fair Value of Stock Options Granted and Intrinsic Value of Stock Options Exercised

A summary of weighted-average grant-date fair value of stock options granted and intrinsic value of stock options exercised is as follows:

	Nine Months Ended
	June 30,
	2011		2010
Weighted-average grant-date fair value per share	$	6.13	$	5.90
Total intrinsic value of stock options exercised (in millions)	$	32.9	$	34.1

Weighted Average Assumptions Used to Calculate Fair Value of Stock Options Granted

The fair value of the stock options granted during the nine months ended June 30, 2011 and 2010 were calculated using the following weighted-average assumptions:

	Nine Months Ended
	June 30,
	2011			2010
Dividend yield		0.0	%		0.0	%
Expected volatility		46.1	%		50.9	%
Average risk-free interest rate		1.2	%		2.4	%
Expected term (in years)		4.1			4.2

Summary of Activity Relating to Restricted Units

The table below summarizes activity relating to Restricted Units for the nine months ended June 30, 2011:

	Number of Shares			Number of Shares
	Underlying			Underlying
	Restricted Units —			Restricted Units —
	Contingent Awards			Time-Based Awards
Outstanding at September 30, 2010		2,867,840			7,795,114
Granted		1,329,988			3,521,636
Earned/released		(1,296,018	)		(3,273,826	)
Forfeited		(360,009	)		(557,123	)
Outstanding at June 30, 2011		2,541,801			7,485,801
Weighted average remaining contractual term of outstanding Restricted Units		1.0 years			1.1 years
Aggregate intrinsic value of outstanding Restricted Units(1)	$	54.6 million		$	160.7 million
Restricted Units vested and expected to vest		2,383,251			6,961,901
Weighted average remaining contractual term of Restricted Units vested and expected to vest		1.0 years			1.1 years
Aggregate intrinsic value of Restricted Units vested and expected to vest(1)	$	51.2 million		$	149.5 million

(1) The aggregate intrinsic value in this table was calculated based on the positive difference between the closing market value of our common stock on June 30, 2011 ($21.47) and the exercise price of the underlying Restricted Units.

Summary of Weighted-Average Grant-Date Fair Value and Intrinsic Value of Restricted Units Vested

A summary of weighted-average grant-date fair value and intrinsic value of all Restricted Units vested is as follows:

	Nine Months Ended,
	June 30,
	2011		2010
Weighted-average grant-date fair value per share	$	17.91	$	15.59
Total intrinsic value of shares vested (in millions)	$	81.8	$	65.2